Prostamax Research Information
Prostate Support Tetrapeptide
AEDG Tetrapeptide Bioregulator for Prostate Research
Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.
Contents
What is Prostamax?
Prostamax is a synthetic tetrapeptide bioregulator with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). It is part of the Khavinson peptide bioregulator family, initially isolated from prostate tissue .
Prostamax has emerged as a promising molecular tool for investigating prostate function, reproductive endocrinology, and tissue homeostasis in research models. Its tissue-specific regulatory activity on prostate cells makes it a valuable compound for reproductive and endocrine research .
Mechanism of Action
Prostamax functions through multiple pathways to support prostate research models:
DNA Interaction
Penetrates cell nuclei and binds to specific DNA sequences, modulating gene transcription
Prostate Cell Regulation
Regulates prostate cell function and tissue homeostasis
Epigenetic Effects
Modulates chromatin structure and gene expression patterns in prostate tissue
Prostamax demonstrates tissue-specific regulatory activity on prostate cells, modulating gene expression and cellular function through DNA interaction and epigenetic mechanisms .
Research Applications
Prostate Research
Prostate function, tissue homeostasis, prostate health studies
Reproductive Endocrinology
Hormonal regulation, male reproductive tissue studies
Cellular Aging
Age-related prostate changes, senescence studies
Epigenetic Studies
Gene expression regulation, chromatin remodeling in prostate tissue
Clinical Studies
Key Research Findings:
- Prostamax demonstrates tissue-specific regulatory activity on prostate cells
- Modulates gene expression in prostate tissue models
- Part of the Khavinson peptide bioregulator system targeting prostate tissues
- Promotes prostate tissue homeostasis through epigenetic mechanisms
Dosing Guide
Reconstitute your freeze-dried vial with 3mL bacteriostatic water. Units assume a standard U-100 insulin syringe (100 units = 1 mL).
Step 1: Select Vial Size
Step 2: Select Dose
Research protocols typically range from 50-200 mcg daily via subcutaneous injection.
Vial Size
20mg Vial
Selected Dose
50 mcg
Doses per Vial
400 doses
Units on Syringe
7.5 units
Volume
0.075 mL
Protocol
Starting
Recommended Schedule
Once daily - Subcutaneous Injection
Do not change your dose unless advised by a qualified professional.
Reconstitution Instructions
Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:
Vial Size
20mg vial with 3mL bac water (6.67 mg/mL)
| Dose | Units on Syringe | Volume (mL) | Protocol |
|---|
Always use a new sterile needle and syringe for each injection.
Safety & Precautions
Do not use if you:
- Are allergic to Prostamax or any components
- Are pregnant or breastfeeding
Storage Instructions:
- Lyophilized: Store at -20°C (-4°F) long-term
- After reconstitution: Refrigerate at 2-8°C (35.6-46.4°F)
- Avoid freeze-thaw cycles after reconstitution
Warning: If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.
References
- Khavinson VKh, et al. Peptide regulation of gene expression in prostate tissue. Bull Exp Biol Med. 2010
- Khavinson VKh, et al. Tissue-specific effects of short peptides on prostate tissue. Adv Gerontol. 2002
- Prostamax Research Overview. Peptide Sciences. 2025
This information is for educational and research purposes only. Always consult with a qualified healthcare professional.
Last updated: August 2026